Citius Pharmaceuticals Inc Stock Forecast

Is Citius Pharmaceuticals Inc stock still a buy after falling -9.25% on Friday?
(Updated on Apr 26, 2024)

CTXR Signals & Forecast

There are few to no technical positive signals at the moment. The Citius Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.739 and $0.80. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -35.46%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Citius Pharmaceuticals Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.625 and $0.612. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Citius Pharmaceuticals Inc finds support just below today's level at $0.625. If this is broken, then the next support from accumulated volume will be at $0.612 and $0.610.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0464 between high and low, or 7.25%. For the last week, the stock has had daily average volatility of 8.53%.

Citius Pharmaceuticals Inc is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CTXR) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Citius Pharmaceuticals Inc to open at $0.664, and during the day (based on 14 day Average True Range), to move between $0.581 and $0.749, which gives a possible trading interval of +/-$0.0837 (+/-12.59%) up or down from last closing price. If Citius Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 25.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.625 (5.99%) than the resistance at $0.736 (10.77%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Citius Pharmaceuticals Inc stock A Buy?

The Citius Pharmaceuticals Inc stock holds several negative signals and despite the positive trend, we believe Citius Pharmaceuticals Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.867 Sell Candidate Unchanged

Predicted Opening Price for Citius Pharmaceuticals Inc of Monday, April 29, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.